Dna breaking news: rosen, leading investor counsel, encourages ginkgo bioworks holdings, inc. investors with losses to inquire about class action investigation - dna

New york, oct. 7, 2021 /prnewswire/ -- why: rosen law firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of ginkgo bioworks holdings, inc. (nyse: dna) resulting from allegations that ginkgo may have issued materially misleading business information to the investing public. so what: if you purchased ginkgo securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
DNA Ratings Summary
DNA Quant Ranking